Microbial Sealant Market Scope
Microbial sealants are sterile, film-forming liquids that block the entry of bacteria into the surgical site. Microbial sealants are usually used as an additional antimicrobial skin preparation after antisepsis and before skin incision. These seals should remain intact and block the migration of the flora from the surrounding skin to the surgical site. Microbial sealants have been shown to reduce the number of bacteria on the skin at the surgical site. Several studies have shown that patients with postoperative infections have a significantly longer hospital stay at high costs. In clean operations, the flora on the patient's skin is the main cause of contamination of the incision. The skin cannot be completely sterilized, so the rebound growth of bacteria can occur during the operation. These sealants are advanced medical devices that quickly replace traditional sutures for wound and cut closure. The benefits of microbial sealants over conventional sutures include minimally invasive, less time consuming, non-blood fluid leakage, and reduced postoperative microbial infections.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
Key Companies Profiled | Kimberly-Clark Corporation (United States), Avanos Medical, Inc. (United States), Halyard Health (United States), Hodgson Sealants (United Kingdom), OsteoRemedies (United States) and Integra Medical (United States) |
CAGR | % |
The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Microbial Sealant market throughout the predicted period.
Kimberly-Clark Corporation (United States), Avanos Medical, Inc. (United States), Halyard Health (United States), Hodgson Sealants (United Kingdom), OsteoRemedies (United States) and Integra Medical (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are N8 Medical (United States) and Adhezion Biomedical, LLC (United Kingdom).
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.
Segmentation Overview
The study have segmented the market of Global Microbial Sealant market by Type , by Application (Cardiothoracic Surgery, Spinal Surgery, Orthopedic Surgery, C-section and Others) and Region with country level break-up.
On the basis of geography, the market of Microbial Sealant has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
region held largest market share in the year 2023.
Market Leaders and their expansionary development strategies
In December 2021, BD (Becton, Dickinson and Company) a leading global medical technology company, announced today it has acquired Tissuemed, Ltd., a privately held firm headquartered in Leeds, England that is an industry leader in developing self-adhesive surgical sealant films
In July , 2021 ,Medcura, Inc., a commercial-stage medical device company, in partnership with ASO, LLC, a major U.S. manufacturer and supplier of first aid products, announced today the launch of a high-performance, antibacterial hemostatic gel, Rapid-Seal®,
Influencing Trend:
Increase the Prevalence of Hospital-Acquired Infections and Lack of Proper Surveillance Systems in Hospitals
Market Growth Drivers:
Increase in the Incidence of Surgical Site Infections, Increasing Preference of These Product among Surgeons Due To Its Efficacy, Unhygienic Conditions In and Around Hospitals and Improper Sterilization Treatment
Challenges:
Unawareness about the Microbial Sealant in the Under Developed Regions
Restraints:
Stringent Regulatory Policies and High Cost of the Product
Opportunities:
Significant Spending Power of Population and A Rise in Technological Advancement
Key Target Audience
Manufacturers of Microbial Sealant, Suppliers and Distributors of Microbial Sealant, End-Users, Potential Investors, Market Research Firms, Regulatory Bodies and Others